BAM
RXDX

Belpointe Asset Management’s Prometheus Biosciences, Inc. Common Stock RXDX Stock Holding History

Belpointe Asset Management’s Portfolio RXDX Stock Details RXDX Fund Activity
Quarter Market Value Status Shares Shares
Change % 		Trade Value Portfolio Weight Portfolio Position
2023
Q2 		– Sell
-186
Closed -$20K – 3679
2023
Q1 		$20K Buy
186
+154
+481% +$16.5K ﹤0.01% 2312
2022
Q4 		$3.52K Buy
+32
New +$3.52K ﹤0.01% 3054